Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

SABCS 2010

8 - 12 Dec 2010
St. Jude Children's Research Hospital, Memphis, United States of America
FIRST trial follow up results
Prof John Robertson - University of Nottingham, UK
FIRST trial follow up results ( Prof John Robertson - University of Nottingham, UK )
1 Feb 2011
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast canc...
Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer ( Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy )
19 Jan 2011
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011
Next generation gene sequencing
Prof Charles Perou - University of North Carolina School of Medicine, USA
Next generation gene sequencing ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
19 Jan 2011
Zoledronic acid disappointment for early breast cancer
Prof Michael Gnant - Medical University of Vienna, Austria
Zoledronic acid disappointment for early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )
19 Jan 2011
NeoALTTO trial results
Prof José Baselga – Massachusetts General Hospital Cancer Center, USA
NeoALTTO trial results ( Prof José Baselga – Massachusetts General Hospital Cancer Center, USA )
19 Jan 2011
Exploiting cancer stress for new therapies
Prof Garth Powis – MD Anderson Cancer Centre, Houston, USA
Exploiting cancer stress for new therapies ( Prof Garth Powis – MD Anderson Cancer Centre, Houston, USA )
19 Jan 2011
Systemic therapy for central nervous system metastases
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Systemic therapy for central nervous system metastases ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
19 Jan 2011
Cancer micrometastases and circulating tumour cells in breast cancer patients
Prof Klaus Pantel - University Medical Center Hamburg-Eppendorf, Germany
Cancer micrometastases and circulating tumour cells in breast cancer patients ( Prof Klaus Pantel - University Medical Center Hamburg-Eppendorf, Germany )
19 Jan 2011
Systems biology for the clinician
Dr Dana Faratian – University of Edinburgh, UK
Systems biology for the clinician ( Dr Dana Faratian – University of Edinburgh, UK )
19 Jan 2011
Understanding stem cells to get abreast of breast cancer
Prof Geoff Lindeman – The Walter and Eliza Hall Institute of Medical Research, P...
Understanding stem cells to get abreast of breast cancer ( Prof Geoff Lindeman – The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia )
19 Jan 2011
Issues with reliability in HER2 testing and avastin for metastatic breast cancer
Dr Edith Perez – Mayo Clinic, Florida, USA
Issues with reliability in HER2 testing and avastin for metastatic breast cancer ( Dr Edith Perez – Mayo Clinic, Florida, USA )
19 Jan 2011
Targeting of breast cancer tumour initiating cells
Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA
Targeting of breast cancer tumour initiating cells ( Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA )
19 Jan 2011
Exemestane potential for hormone-receptor positive, early-stage breast cancer in...
Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA
Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting ( Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA )
19 Jan 2011
Pertuzumab and trastuzumab combination improved efficacy for women with HER2-pos...
Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer ( Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy )
18 Jan 2011
Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer
Prof Michael Untch - Helios Clinic, Berlin, Germany
Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
18 Jan 2011
Combination therapy reduced HER2-positive breast cancers
Prof José Baselga - Massachusetts General Hospital Cancer Center, USA
Combination therapy reduced HER2-positive breast cancers ( Prof José Baselga - Massachusetts General Hospital Cancer Center, USA )
18 Jan 2011
CTCs predicted recurrence and death in patients with early-stage breast cancer
Dr Brigitte Rack - Munich University Hospital, Germany
CTCs predicted recurrence and death in patients with early-stage breast cancer ( Dr Brigitte Rack - Munich University Hospital, Germany )
18 Jan 2011
High CTC levels predicted poor outcome in metastatic breast cancer
Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France
High CTC levels predicted poor outcome in metastatic breast cancer ( Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France )
18 Jan 2011
Denosumab delayed first skeletal-related side effect
Prof Alison Stopeck - University of Arizona, Tucson, USA
Denosumab delayed first skeletal-related side effect ( Prof Alison Stopeck - University of Arizona, Tucson, USA )
18 Jan 2011
CTCs predict poor outcome from blood stem cell transplantation therapy for metas...
Hui Gao - MD Anderson Cancer Center, Houston, USA
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer ( Hui Gao - MD Anderson Cancer Center, Houston, USA )
18 Jan 2011